Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Hantaan virus (HTNV) and Puumala virus (PUUV) Gn and Gc glycoproteins are the essential surface proteins of these orthohantaviruses, which are the primary causative agents of hemorrhagic fever with renal syndrome (HFRS) in Eurasia (PMID: 30715428). These glycoproteins are encoded by the viral M genomic segment and are synthesized as a precursor polyprotein that is co-translationally cleaved into Gn and Gc subunits (UniProt: P08668, P23457). On the viral envelope, they assemble into spikes that mediate attachment to host cell receptors, such as beta-3 integrins, and facilitate membrane fusion following endocytosis (PMID: 24501065). As the primary targets for the host's neutralizing antibody response, these glycoproteins are the central components of vaccine candidates, including bivalent DNA vaccines like pHTN-M and pPUU-M, which have been evaluated in clinical trials (PMID: 24501065). Targeting both HTNV and PUUV glycoproteins is a strategic approach to provide broad-spectrum protection against various hantavirus strains that cause HFRS across different geographic regions.
Induction of neutralizing antibodies that bind to the Gn and Gc surface glycoproteins, preventing viral attachment to host cell receptors and inhibiting pH-dependent membrane fusion (PMID: 30715428).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hantaan virus and Puumala virus envelope glycoproteins Gn and Gc (HTNV Gn-Gc and PUUV Gn-Gc).